Published in J Med Screen on January 01, 1994
A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs. J Gastrointest Cancer (2015) 0.86
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol (2008) 4.78
What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer (2009) 4.31
Smoking and risk of rheumatoid arthritis. J Rheumatol (1993) 3.63
Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ (1996) 3.56
Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics (1982) 3.18
Prospective randomised trial in 1062 infants of diet low in saturated fat and cholesterol. Lancet (1995) 3.13
A computer program package for relative survival analysis. Comput Programs Biomed (1985) 3.10
Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis (1978) 3.08
Mental disorders and cause-specific mortality. Br J Psychiatry (2001) 2.99
Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet (1994) 2.83
Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ (1995) 2.80
Osteoarthritis of finger joints in Finns aged 30 or over: prevalence, determinants, and association with mortality. Ann Rheum Dis (2003) 2.75
Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67
Prevalence, determinants, and consequences of chronic neck pain in Finland. Am J Epidemiol (1991) 2.59
Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol (1991) 2.43
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst (2000) 2.34
Determinants of sciatica and low-back pain. Spine (Phila Pa 1976) (1991) 2.29
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Reliability and validity of interview data on chronic diseases. The Mini-Finland Health Survey. J Clin Epidemiol (1993) 2.22
Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr (2005) 2.14
The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev (2005) 2.08
Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976-92. BMJ (1994) 2.04
Determinants of weight gain and overweight in adult Finns. Eur J Clin Nutr (1991) 2.04
Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion. J Rheumatol (2000) 1.87
Analysis of polychlorinated biphenyls (PCBs) in human serum. Environ Health Perspect (1985) 1.86
Cancer registration: principles and methods. Analysis of survival. IARC Sci Publ (1991) 1.84
Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol (1994) 1.82
Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med (1999) 1.82
Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer (2003) 1.79
Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J (Clin Res Ed) (1984) 1.77
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis (2000) 1.74
Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol (1992) 1.74
Incidence of childhood cancer in Finland. J Natl Cancer Inst (1975) 1.73
Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72
Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer (2004) 1.68
Long-term cost and life-expectancy consequences of hypertension. J Hypertens (1998) 1.68
Diagnosis of ectopic pregnancy by vaginal ultrasonography in combination with a discriminatory serum hCG level of 1000 IU/l (IRP) Br J Obstet Gynaecol (1990) 1.65
Serum C-reactive protein does not predict rheumatoid arthritis. J Rheumatol (2000) 1.65
Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut (2008) 1.64
Toward a comparison of survival in American and European cancer patients. Cancer (2000) 1.63
Radioimmunoassay of plasma renin activity. Clin Chem (1976) 1.62
Prevalence of severe dementia in Finland. Neurology (1985) 1.62
Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N Engl J Med (1997) 1.61
Postural balance in a random sample of 7,979 subjects aged 30 years and over. Gerontology (2006) 1.61
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl (1986) 1.60
Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study. J Intern Med (2012) 1.59
The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl (1983) 1.59
Increase of allergen-specific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to Helicobacter pylori infections. Clin Exp Allergy (2002) 1.59
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol (1993) 1.58
Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol (1996) 1.58
Outcome-based equity in the treatment of colon cancer patients in Finland. Int J Technol Assess Health Care (1989) 1.57
Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56
Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol (1997) 1.56
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55
Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer (1986) 1.55
Survival of breast cancer patients after subsequent term pregnancy: "healthy mother effect". Am J Obstet Gynecol (1994) 1.53
Normal early pregnancy: serum hCG levels and vaginal ultrasonography findings. Br J Obstet Gynaecol (1990) 1.53
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia (2005) 1.52
Measurement of the complex between prostate-specific antigen and alpha1-protease inhibitor in serum. Clin Chem (1999) 1.52
Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. Br J Obstet Gynaecol (1993) 1.51
Cancer in the offspring of fathers in hydrocarbon-related occupations. Br J Prev Soc Med (1976) 1.51
Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987. Eur J Cancer (1996) 1.50
Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease? Arch Intern Med (2001) 1.50
When does rheumatoid disease start? Arthritis Rheum (1985) 1.50
Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect (1997) 1.49
Parity and risk of hip fracture in postmenopausal women. Osteoporos Int (2010) 1.49
Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction. Scand J Clin Lab Invest (2004) 1.47
Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancer. Scand J Clin Lab Invest (2001) 1.47
Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin Chem (1995) 1.46
Parity and obesity. J Epidemiol Community Health (1981) 1.46
Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite and N-nitroso compounds: a follow-up study. Int J Cancer (1999) 1.46
Correlation of HbA1C, glycated serum proteins and albumin, and fructosamine with the 24-h glucose profile of insulin-dependent pregnant diabetics. Clin Chem (1989) 1.45
Testicular cancer in Europe and the USA: survival still rising among older patients. Ann Oncol (2012) 1.45
Three assays for glycohemoglobin compared. Clin Chem (1995) 1.45
Glycophorin A biodosimetry in Chernobyl cleanup workers from the Baltic countries. BMJ (1996) 1.45
Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol (1988) 1.45